Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 1/20 | 0.40 |
| ▸ | PREP | P48147 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6203338 | 0.82 | CTSK (0.50) | CTSKPREPUSP2SMN1; SMN2BCHE | |
| SCHEMBL900813 | 0.76 | USP2 (0.37) | CTSKPREPUSP2SMN1; SMN2CHRM2 | |
| SCHEMBL6203340 | 0.76 | CTSK (0.45) | CTSKPREPUSP2SMN1; SMN2BCHE | |
| SCHEMBL17047027 | 0.75 | MAPK1 (0.39) | SMN1; SMN2BCHE | |
| SCHEMBL6023105 | 0.73 | CTSK (0.50) | CTSKPREPUSP2SMN1; SMN2CHRM2 | |
| SCHEMBL222920 | 0.70 | PREP (0.53) | CTSKPREPUSP2SMN1; SMN2EPHX1 | |
| SCHEMBL6023110 | 0.69 | CTSK (0.43) | CTSKPREPUSP2SMN1; SMN2CHRM2 | |
| SCHEMBL7909692 | 0.68 | USP2 (0.42) | PREPUSP2SMN1; SMN2NR1H2HPGD | |
| SCHEMBL3603586 | 0.67 | CTSK (0.72) | CTSKPREPUSP2SMN1; SMN2CHRM2 | |
| SCHEMBL900812 | 0.67 | CTSK (0.67) | CTSKPREPUSP2SMN1; SMN2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250376477-A1 | ANALGESIC DELTA OPIOID RECEPTOR BITOPIC LIGANDS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2025-12-11 | — | — | US | disclosed |
| US-20230310435-A1 | HOST DEFENSE PROTEIN (HDP) MIMETICS FOR PROPHYLAXIS AND/OR TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT | INNOVATION PHARMACEUTICALS INC. (US) | 2023-10-05 | — | — | US | disclosed |
| US-11666571-B2 | Host defense protein (HDP) mimetics for prophylaxis and/or treatment of inflammatory diseases of the gastrointestinal tract | INNOVATION PHARMACEUTICALS INC. (US) | 2023-06-06 | — | — | US | disclosed |
| EP-4168030-A1 | NOVEL ANTIBACTERIAL HYDROGELS | NewSouth Innovations Pty Limited (AU) | 2023-04-26 | — | — | EP | disclosed |
| US-20220267268-A1 | NEW TRICYCLIC 5-HT2 ANTAGONISTS | ANAMAR AB (SE) | 2022-08-25 | — | — | US | disclosed |
| US-20220096641-A1 | PYRROLOBENZODIAZEPINE DIMER COMPOUND WITH IMPROVED SAFETY AND USE THEREOF | LEGOCHEM BIOSCIENCES, INC. (KR) | 2022-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250376477-A1 | ANALGESIC DELTA OPIOID RECEPTOR BITOPIC LIGANDS | OPRD1, OPRK1, OPRM1 | CTSK 2905/4885PREP 1281/4885USP2 2527/4885 |
| US-11666571-B2 | Host defense protein (HDP) mimetics for prophylaxis and/or treatment of inflammatory diseases of the gastrointestinal tract | FABP2, HMGB1, MASP2 | CTSK 1255/4885PREP 222/4885USP2 2083/4885 |
| US-20220267268-A1 | NEW TRICYCLIC 5-HT2 ANTAGONISTS | HTR2B, HTR2C, TPH2 | CTSK 4005/4885PREP 2717/4885USP2 1975/4885 |
| US-20220096641-A1 | PYRROLOBENZODIAZEPINE DIMER COMPOUND WITH IMPROVED SAFETY AND USE THEREOF | BID, CDC42, BAD | CTSK 3095/4885PREP 1475/4885USP2 4221/4885 |
| US-20230310435-A1 | HOST DEFENSE PROTEIN (HDP) MIMETICS FOR PROPHYLAXIS AND/OR TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT | FABP2, HMGB1, MASP2 | CTSK 1255/4885PREP 222/4885USP2 2083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.